Clinical Trial Update: Neuroinflammation in Patients With OCD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neuroinflammation in obsessive-compulsive disorder has been suspended. No details on suspension were provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Obsessive-Compulsive Disorder | Phase 2 | Status: SUSPENDED